Faster treatment best in high-risk acute coronary syndrome patientsBut low-risk patients can safely wait a few days if necessary MS drug proves promising for cardiomyopathy Lumbar fusion OK for elderly patients Jumpin’ JUPITER! People with normal cholesterol may benefit from statin therapy Katz CEO to lead NACDS Andrew Giancamilli, CEO of Katz Group North America and Snyder's Drug Stores, is the newly appointed chairman of the board of the NACDS, Home INR monitoring a safe alternative to clinic-based testing Alta. doctors looking to help shape ‘superboard’ Think you’re superior to an IMG? Think again Romanow report languishing in the bowels of history Drug-eluting stents better for diabetic patients First Previous 3436 3437 3438
